Grifols, S.A. (BME:GRF)
9.56
-0.11 (-1.10%)
Sep 16, 2026, 5:35 PM CET
Grifols Employees
Grifols had 25,000 employees as of March 31, 2026. The number of employees increased by 1,200 or 5.04% compared to the same quarter last year.
Employees
25,000
Change
1,200
Growth
5.04%
Revenue / Employee
€293,808
Profits / Employee
€17,895
Market Cap
5.75B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 25,000 | 1,200 | 5.04% | 25,000 | 0 |
| Dec 31, 2025 | 25,258 | 1,425 | 5.98% | 25,258 | 0 |
| Sep 30, 2025 | 23,800 | 800 | 3.48% | 23,800 | 0 |
| Mar 31, 2025 | 23,800 | 800 | 3.48% | 23,800 | 0 |
| Dec 31, 2024 | 23,833 | 89 | 0.37% | 23,833 | 0 |
| Sep 30, 2024 | 23,000 | -1,000 | -4.17% | 23,000 | 0 |
| Jun 30, 2024 | 23,505 | -126 | -0.53% | 23,505 | 0 |
| Mar 31, 2024 | 23,000 | -1,000 | -4.17% | 23,000 | 0 |
| Dec 31, 2023 | 23,744 | -2,582 | -9.81% | 23,744 | 0 |
| Sep 30, 2023 | 24,000 | -3,584 | -12.99% | 24,000 | 0 |
| Jun 30, 2023 | 23,631 | -3,953 | -14.33% | 23,631 | 0 |
| Mar 31, 2023 | 24,000 | 755 | 3.25% | 24,000 | 0 |
| Dec 31, 2022 | 26,326 | 3,081 | 13.25% | 26,326 | 0 |
| Jun 30, 2022 | 27,584 | 4,153 | 17.72% | 27,584 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Faes Farma | 2,611 |
| Laboratorios Farmaceuticos Rovi | 2,470 |
| Almirall | 2,097 |
| Clínica Baviera | 2,009 |
| Laboratorio Reig Jofre | 1,400 |
| Prim, S.A. | 959 |
| Atrys Health | 758 |
| Pharma Mar | 505 |
Grifols News
- 27 days ago - Number of adverse reactions by plasma donors reduced after Grifols flagged misclassification: Health Canada - CBC News
- 4 weeks ago - Temporary pause in paid plasma collection at Grifols' Canadian clinics 'a reasonable step': cardiologist - CBC News
- 4 weeks ago - Canadian plasma clinics pause collections after deaths of two donors - The Guardian
- 4 weeks ago - Private clinic Grifols says it's pausing all plasma collection in Canada - CBC News
- 5 weeks ago - Grifols completes clinical portion of SPARTA trial - TheFly
- 5 weeks ago - Grifols Announces Last Patient Last Visit in SPARTA, its Phase 3 Outcomes Study of Prolastin®-C in Patients With Emphysema Due to Alpha-1 Antitrypsin Deficiency - GlobeNewsWire
- 7 weeks ago - Grifols says EXCELL Phase 3 trial timeline not ‘new development or a delay’ - TheFly
- 7 weeks ago - Grifols Q2 Earnings Call Highlights - MarketBeat